Excellence in Oncology 2012 to be organized under the auspices of the EORTC
22 Dec 2011
22-25 February 2012, Istanbul, Turkey
Introducing EiO 2012 – The second in a series of annual international conferences in the field of oncology featuring distinguished experts selectively presenting the latest scientific findings and advances in oncology, as these relate to clinical practice.
- A plethora of distinguished speakers from across the globe
- A comprehensive annual review of the latest emerging evidence and clinical practices
- Exclusive structured and unstructured networking opportunities
- Awards and scientific recognition for the best abstract submissions
- CME/CPD accreditation provided
Main thematic axes:
- Prevention & Early Diagnosis of Cancer
- Diagnosis & Staging of Cancer
- Treatment of Cancer and Supportive Care of Cancer Patients
Who should attend?
The Conference is addressed primarily to medical oncologists, surgical oncologists and radiation oncologists while it is also of interest to pathologists, radiologists and translational-oriented researchers.
Days to remember:
Last day to register at the “early bird” fee: 17 June 2011
Last day to submit your abstract: 30 September 2011
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023